EPAM vs NRIX · P/E 14, rev $2.81B vs rev $15.3M
EPAM Systems Inc (EPAM) versus Nurix Therapeutics Inc (NRIX) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Nurix Therapeutics Inc (NRIX) is a biotechnology company listed on NASDAQ.
Latest reported EPAM revenue for 2026-06-30 was $2.81B. Net income was $185.5M. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported NRIX revenue for 2026-05-31 was $15.3M. Net income was -$176.7M. NRIX currently screens at market cap $1.77B.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. NRIX currently screens at market cap $1.77B.
Not investment advice. Open the EPAM and NRIX stock pages for the full models.
Not investment advice.